Analystreport

Millendo Therapeutics Inc (NASDAQ: MLND) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $26.00 to $25.00. They now have an "outperform" rating on the stock.

Millendo Therapeutics, Inc. - Common Stock  (MLND) 
Last millendo therapeutics, inc. - common stock earnings: 11/13 08:30 am Check Earnings Report